Jens Kringelum

Company: Evaxion Biotech

Job title: Director, Genomic Immuno-Oncology

Seminars:

Current Identification of Neoantigens & How this Translates to Preclinical Settings 11:30 am

Considering the current overview of identification and prioritisation of cancer neoantigens Highlighting the limitations of current neoantigen prediction pipelines Discussing broader challenges associated with cancer neoantigen vaccinesRead more

day: Track A - Day 1 AM